The Daily Wrap – July 21, 2026

The United States is escalating geopolitical and trade tensions, launching new strikes against Iran and imposing an additional 50% tariff on certain Canadian goods. Amidst this volatility, several major companies including General Motors, 3M, and Charles Schwab reported strong quarterly results, while Apple secured a key approval to launch its AI features in China through local partnerships. Meanwhile, significant legal battles are unfolding as a federal judge temporarily blocked the Paramount-Warner merger on antitrust grounds and Novo Nordisk sued rival Eli Lilly for false advertising.

A news podcast encapsulating the most salient market news, brought to you by Finextra Pro and powered by Communify.

Open Finextra Pro now!

Transcript

SPEAKER_00 0:00

From Phenextra Pro in Tampa, it's Tuesday, July 21, and I'm Rachel Anderson with the Daily Rap. We begin with escalating tensions in the Middle East. The U.S. has completed a fresh round of strikes against Iran, while Yemen's Houthi militants have threatened a naval blockade on Saudi Arabia, putting global oil supplies at further risk. This comes as regional mediators are reportedly pushing for a 10-day ceasefire. The uncertainty has sent international benchmark Brent Crude back above $90 a barrel. The White House has announced an additional 50% tariff on approximately $20 billion worth of Canadian goods, including wine and hockey sticks, citing what it calls discriminatory treatment of American products. The move is set to take effect in mid-August and adds another layer of tension to the ongoing renegotiation of the U.S.-Mexico-Canada trade agreement. General Motors is in the spotlight after beating second quarter expectations and raising its full-year earnings forecast. The automaker cited resilient consumer demand and stable vehicle pricing, with its average transaction price holding at $52,000. 3M stock is soaring after a big beaten raise quarter. The industrial conglomerate reported earnings of $2.40 per share, easily topping estimates, and raised its full year guidance. CEO William Brown credited the progress on the company's strategic priorities for delivering mid-single-digit sales growth and robust operating margins. Charles Schwab announced that its profits surged 32% from a year ago. The brokerage was fueled by a frenzy of client activity, with daily average trades hitting a record $11.9 million as customers bought the dip during a volatile quarter. The firm's net interest income also rose 19%, and total client assets on its platform swelled to over $13 trillion. In tech, a breakthrough for Apple in a critical market. Chinese regulators have officially approved Apple Intelligence for launch in the country. The approval was secured through a strategic partnership to integrate models from local giants Alibaba and Baidu. The move validates CEO Tim Cook's Capital Light partnership-driven AI strategy, which allows Apple to navigate different regulatory environments without bearing the massive cost of building its own proprietary models from the ground up. Shares of NeoCloud company Nebius are jumping after NVIDIA officially disclosed it holds a 9.3% stake in the firm. The filing quantifies NVIDIA's significant investment in the company, reinforcing its strategy of backing key customers to lock-in demand for its AI processors and bolstering investor confidence in the entire NeoCloud sector. A federal judge in California has temporarily blocked the proposed $81 billion merger of Paramount and Warner Brothers Discovery. The judge granted a 14-day restraining order, stating the court can presume the deal is likely to violate antitrust laws. The ruling is a significant win for the dozen states challenging the merger and means the companies will be barred from closing the deal while the case proceeds, potentially triggering a costly ticking fee for Paramount if the delay extends past September. A new battle is brewing in the lucrative weight loss drug market. Novo Nordisk is suing its rival Eli Lilly for false advertising. In the lawsuit, Novo accuses Lilly of deceptively claiming its drugs Zetbound and Munjaro outperform Novo's Wagovy and Ozempic by comparing the highest doses of its medicines to older, lower doses of Novo's drugs, and is seeking a court order to have the ads withdrawn. U.S. Treasury yields moved up as investors keep an eye on the latest out of the Middle East. The 10-year was at 4.62%, the two-year yield was at 4.24%, and the 30-year bond yield was at 5.13%. And now let's check the scoreboard. Wall Street is seeing gains on the backs of chip stocks and positive corporate earnings. Midday, the SP was up around 8 tenths of a percent, the Dow was up almost a quarter of a percent, and the NASDAQ was leading the charge, up over 1.3%. That's all for your daily rap today. I'm Rachel Anderson from Fenextra Pro, turning data into stories.